article thumbnail

Pharma Distribution: Carving New Ground

Pharmaceutical Commerce

Pharmaceutical distribution today is anything but monolithic. While companies in this space are grappling with issues ranging from inflation and supply chain disruption to workforce scarcity and DSCSA implementation, there’s still plenty of room for smaller players to stake out part of the terrain to call their own.

article thumbnail

Expert Discusses Unique Challenges of Distributing Specialty Drugs

Pharmacy Times

Natalie Bedford, senior vice president, US Pharmaceutical Distribution Services at McKesson, discusses the unique challenges of distributing specialty drugs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Abiogen acquires EffRx to fortify bone disease portfolio

Pharmaceutical Technology

The Italian pharmaceutical company Abiogen Pharma completed an acquisition of a 97.09% stake in the Swiss orphan conditions-focused EffRx Pharmaceuticals on May 29. Altamedics specialises in pharmaceutical distribution in hospital settings.

article thumbnail

Leading API biologics (protein and peptide) companies in contract marketing

Pharmaceutical Technology

The list includes companies that provide various products and services, including: Manufacturing of reagents for peptide synthesis Large-scale manufacturing of peptides Manufacturing of biologically active peptides and complex organic molecules Scale-up of complex peptides Development and production of therapeutic proteins, such as soluble proteins (..)

Leads 40
article thumbnail

Stakeholder Mapping for Pharmaceutical Products

Celeritas

Begin the stakeholder mapping process by making a precise list of actors who will play a part in the pharmaceutical distribution process. It is therefore important to develop a visual hierarchy of the Key Opinion Leaders of the industry, organized according to their level of authority, influence, and relevance.

article thumbnail

An MSL guide to Veterinarian Meeting Strategy

Celeritas

It’s important to first identify all actors who will play a part in the pharmaceutical distribution process. But what determines which members of the medical community will be valuable to approach for any given proposition? Who are Key Opinion Leaders (KOLs) in the Veterinarian field?